<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">283</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2009-5-3-71-73</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL CASE</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="ru">ВОЗМОЖНОСТИ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ ДИССЕМИНИРОВАННОГО РАКА ПОЧКИ: ОПИСАНИЕ КЛИНИЧЕСКОГО СЛУЧАЯ</article-title><trans-title-group xml:lang="en"><trans-title/></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname></surname><given-names></given-names></name><name xml:lang="ru"><surname>Гриднева</surname><given-names>Я. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>vsevolodmatveev@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname></surname><given-names></given-names></name><name xml:lang="ru"><surname>Матвеев</surname><given-names>В. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>vsevolodmatveev@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname></surname><given-names></given-names></name><name xml:lang="ru"><surname>Перлин</surname><given-names>Д. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>vsevolodmatveev@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname></surname><given-names></given-names></name><name xml:lang="ru"><surname>Фу</surname><given-names>Р. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>vsevolodmatveev@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname></surname><given-names></given-names></name><name xml:lang="ru"><surname>Алешин</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>vsevolodmatveev@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname></surname><given-names></given-names></name><name xml:lang="ru"><surname>Белов</surname><given-names>Д. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>vsevolodmatveev@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ГУ РОНЦ им. Н.Н. Блохина РАМН, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2009-09-30" publication-format="electronic"><day>30</day><month>09</month><year>2009</year></pub-date><volume>5</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>71</fpage><lpage>73</lpage><history><date date-type="received" iso-8601-date="2014-08-04"><day>04</day><month>08</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-08-04"><day>04</day><month>08</month><year>2014</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/283">https://oncourology.abvpress.ru/oncur/article/view/283</self-uri><abstract xml:lang="ru"><p>Gриведено клиническое наблюдение больной раком правой почки T2N0M0 с метастазами в левую почку и головной мозг.</p></abstract><trans-abstract xml:lang="en"><p/></trans-abstract><kwd-group xml:lang="ru"><kwd>лечение</kwd><kwd>диссеминированный рак почки</kwd><kwd>клинический случай</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Клиническая онкоурология. Под ред. Б.П. Матвеева. М.: Векрдана, 2003.</mixed-citation><mixed-citation xml:lang="ru">Клиническая онкоурология. Под ред. Б.П. Матвеева. М.: Векрдана, 2003.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Fisher R.I., Rosenberg S.A., Sznol M. et al. High-dose aldesleukin in renal cell carcinoma: long-term survival update. Cancer J Sci Am 1997;3: 70—2.</mixed-citation><mixed-citation xml:lang="ru">Fisher R.I., Rosenberg S.A., Sznol M. et al. High-dose aldesleukin in renal cell carcinoma: long-term survival update. Cancer J Sci Am 1997;3: 70—2.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Gilboa E., Nair S.K., Lyerly H.K. Immunotherapy of cancer with dendriticcell-based vaccines. Cancer Immunol Immunother 1998;46:82—7.</mixed-citation><mixed-citation xml:lang="ru">Gilboa E., Nair S.K., Lyerly H.K. Immunotherapy of cancer with dendriticcell-based vaccines. Cancer Immunol Immunother 1998;46:82—7.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Childs R., Chernoff A., Contentin N. et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogenic peripheral-blood stem-cell transplantation. N Engl J Med 2000;343:750—8.</mixed-citation><mixed-citation xml:lang="ru">Childs R., Chernoff A., Contentin N. et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogenic peripheral-blood stem-cell transplantation. N Engl J Med 2000;343:750—8.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Keane T., Gilatt D., Evans C.P. et al. Current and Future Trends in the Treatment of Renal Cancer. Eur Urol Suppl 2007;6:374—84.</mixed-citation><mixed-citation xml:lang="ru">Keane T., Gilatt D., Evans C.P. et al. Current and Future Trends in the Treatment of Renal Cancer. Eur Urol Suppl 2007;6:374—84.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
